These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 20021342)
1. Estrogens as potential therapeutic agents in multiple sclerosis. Niino M; Hirotani M; Fukazawa T; Kikuchi S; Sasaki H Cent Nerv Syst Agents Med Chem; 2009 Jun; 9(2):87-94. PubMed ID: 20021342 [TBL] [Abstract][Full Text] [Related]
2. Estrogen treatment induces a novel population of regulatory cells, which suppresses experimental autoimmune encephalomyelitis. Matejuk A; Bakke AC; Hopke C; Dwyer J; Vandenbark AA; Offner H J Neurosci Res; 2004 Jul; 77(1):119-26. PubMed ID: 15197745 [TBL] [Abstract][Full Text] [Related]
8. Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis. Berard JL; Zarruk JG; Arbour N; Prat A; Yong VW; Jacques FH; Akira S; David S Glia; 2012 Jul; 60(7):1145-59. PubMed ID: 22499213 [TBL] [Abstract][Full Text] [Related]
9. Pregnancy level of estrogen attenuates experimental autoimmune encephalomyelitis in both ovariectomized and pregnant C57BL/6 mice through expansion of Treg and Th2 cells. Haghmorad D; Amini AA; Mahmoudi MB; Rastin M; Hosseini M; Mahmoudi M J Neuroimmunol; 2014 Dec; 277(1-2):85-95. PubMed ID: 25457839 [TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor α signaling in T lymphocytes is required for estradiol-mediated inhibition of Th1 and Th17 cell differentiation and protection against experimental autoimmune encephalomyelitis. Lélu K; Laffont S; Delpy L; Paulet PE; Périnat T; Tschanz SA; Pelletier L; Engelhardt B; Guéry JC J Immunol; 2011 Sep; 187(5):2386-93. PubMed ID: 21810607 [TBL] [Abstract][Full Text] [Related]
11. Estrogen-mediated protection of experimental autoimmune encephalomyelitis: Lessons from the dissection of estrogen receptor-signaling in vivo. Laffont S; Garnier L; Lélu K; Guéry JC Biomed J; 2015; 38(3):194-205. PubMed ID: 26068028 [TBL] [Abstract][Full Text] [Related]
12. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate. Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599 [TBL] [Abstract][Full Text] [Related]
13. The synthetic retinoid Am80 delays recovery in a model of multiple sclerosis by modulating myeloid-derived suppressor cell fate and viability. Moliné-Velázquez V; Ortega MC; Vila del Sol V; Melero-Jerez C; de Castro F; Clemente D Neurobiol Dis; 2014 Jul; 67():149-64. PubMed ID: 24709559 [TBL] [Abstract][Full Text] [Related]